Different functional domains in the cytoplasmic tail of glycoprotein B are involved in Epstein-Barr virus-induced membrane fusion

Virology

Volumn 290, Issue 1, 2001, Pages 106-114

  Haan, Keith M ^a   Kyeong Lee, Suk ^b   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN B; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BIOASSAY; CELL FUSION; CHO CELL; DAUDI CELL; DELETION MUTANT; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOCYTE MEMBRANE; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

CRICETINAE; CRICETULUS GRISEUS; HUMAN HERPESVIRUS 4;

EID: 0035841670     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1141     Document Type: Article

References (58)

1. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
2. Truncation of the carboxy-terminal 28 amino acids of glycoprotein B specified by herpes simplex virus type 1 mutant amb1511-7 causes extensive cell fusion
3. An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ
4. Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells
5. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion
6. Functional regions and structural features of the gB glycoprotein of herpes simplex virus type 1. An analysis of linker insertion mutants
7. Linker-insertion nonsense and restriction-site deletion mutations of the gB glycoprotein gene of herpes simplex virus type 1
8. Epstein-Barr virus infection
9. Analysis of the contributions of herpes simplex virus type 1 membrane proteins to the induction of cell-cell fusion
10. Nucleotide sequence of a herpes simplex virus type 1 gene that causes cell fusion
11. Identification of an Epstein-Barr virus glycoprotein which is antigenically homologous to the varicella-zoster virus glycoprotein II and the herpes simplex virus glycoprotein B
12. CD21-dependent infection of an epithelial cell line, 293, by Epstein-Barr virus
13. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2
14. Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted
15. Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B
16. Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110
17. Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB
18. Epstein-Barr virus entry utilizing HLA-DP or DQ as cofactors
19. The UL45 gene product is required for herpes simplex virus type 1 glycoprotein B-induced fusion
20. Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells
21. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity
22. Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo
23. Epstein-Barr virus glycoproteins - Beyond gp350/220
24. Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands
25. Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment
26. Epstein-Barr virus and its replication
27. Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle
28. Pseudorabies virus glycoprotein M inhibits membrane fusion
29. Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks
30. Four consecutive arginine residues at positions 836-839 of EBV gp110 determine intracellular localization of gp110
31. The Epstein-Barr virus glycoprotein 110 carboxyl-terminal tail domain is essential for lytic virus replication
32. The Epstein-Barr virus (EBV) BZLF2 gene product associates with gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells
33. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
34. Epstein-Barr virus infection and replication in a human epithelial cell system
35. Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI I fragment
36. Characterization of the UL10 gene product of herpes simplex virus type 1 and investigation of its role in vivo
37. Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells
38. Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells
39. Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2)
40. Efficient selection for high-expression transfectants with a novel eukaryotic vector
41. Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame
42. Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells
43. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay
44. Glycoprotein H of pseudorabies virus is essential for entry and cell-to-cell spread of the virus
45. Epstein-Barr virus genome may encode a protein showing significant amino acid and predicted secondary structure homology with glycoprotein B of herpes simplex virus 1
46. Function of glycoprotein B homologues of the family herpesviridae
47. Cell fusion induced by herpes simplexvirus gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate
48. The single base pair substitution responsible for the Syn phenotype of herpes simplex virus type 1, strain MP
49. Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpevirus 1
50. Entry and egress of varicella virus blocked by same anti-gH monoclonal antibody
51. Epstein-Barr virus entry into cells
52. Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen
53. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis
54. Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system
55. Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect
56. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells
57. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein
58. Epstein-Barr virus infection of human gastric carcinoma cells: Implication of the existence of a new virus receptor different from CD21